Identification of novel tumor antigens with patient-derived immune-selected antibodies

Article

Abstract: The identification of tumor antigens capable of eliciting an immune response in vivo may be an effec

Palabras claves:

Breast Cancer, Germinal center, Immune response, Neuroplastin/SDR-1, Sentinel lymph node, Tumor antigen

Autores:

Beesley P., Claffey K.P., Daniel Rodríguez-Pinto, Gundelfinger E.D., Han D.K., Keough M.P., Phoenix K.N., Sparkowski J., Vumbaca F.

Fuentes:

scopus